Status:
COMPLETED
The Effects of Nicardipine and Esmolol Applied for Controlled Hypotension
Lead Sponsor:
Yuzuncu Yil University
Conditions:
Hypotension
Surgery-Complications
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
In this study, the effects of nicardipine and esmolol applied for controlled hypotension in rhinoplasty on hemodynamics and regional renal oxygenation will be investigated.
Detailed Description
The procedure to be applied to the cases to be included in the study: Patients randomized by the sealed envelope method will be divided into 2 groups (40 patients in each group). The sealed envelope...
Eligibility Criteria
Inclusion
- Between 18-60 years of age,
- ASA I-II,
- undergoing elective rhinoplasty surgery,
- it was decided to apply controlled hypotension,
- BMI (body mass index) between 18-25 kg/m2,
- informed about the subject and
- patients with written consent
Exclusion
- ASA III-IV patients,
- hypertension disease,
- using anticoagulant medication,
- pregnancy,
- kidney failure,
- bleeding diathesis,
- active infection,
- allergy to drugs to be used,
- BMI≥30,
- refusing to participate in the study,
- hypothermic,
- patients taking antibiotics, anticonvulsants, antiarrhythmics, cholinesterase inhibitors
Key Trial Info
Start Date :
May 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05430724
Start Date
May 12 2022
End Date
August 30 2022
Last Update
September 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Van yuzuncu Yıl University, Dursun Odabas Medical Center
Van, Turkey (Türkiye), 65080